Upgrade to SI Premium - Free Trial

UPDATE: Evercore ISI Starts Dicerna Pharmaceuticals (DRNA) at Outperform; Alnylam Case Appears Favorable

January 15, 2018 2:36 PM
(Updated - January 16, 2018 5:57 AM EST)

(updated to add analyst comments)Evercore ISI initiates coverage on Dicerna Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot New Coverage Litigation New Coverage